Press release
Prostate Cancer Drugs Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis
Prostate Cancer Drugs
What Is the Current Prostate Cancer Drugs Market Size and Its Estimated Growth Rate?
The prostate cancer drugs market has seen strong growth in recent years. It will grow from $18.53 billion in 2024 to $19.77 billion in 2025, at a CAGR of 6.7%. The growth drivers include an aging population, higher diagnosis rates, innovation in drugs, increased awareness and education, and expanding reimbursement and insurance coverage.
The prostate cancer drugs market will expand strongly to $25.13 billion in 2029, growing at a CAGR of 6.2%. Growth drivers include increasing incidence rates, rising investment in R&D, favorable policies, and expanding access in developing markets. Trends include precision and personalized medicine, immunotherapy, combination treatments, biomarker use, and remote care options.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2592
How Are Emerging Segments Shaping the Prostate Cancer Drugs Market Landscape?
The prostate cancer drugs market covered in this report is segmented -
1) By Type: Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer
2) By Therapy: Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy
3) By End User: Hospitals, Clinics, Other End-Users
Subsegments:
1) By Hormone Sensitive Prostate Cancer: Early-Stage Prostate Cancer, Locally Advanced Prostate Cancer, Metastatic Prostate Cancer
2) By Hormone Refractory Prostate Cancer: Castration-Resistant Prostate Cancer (CRPC), Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2592&type=smp
Which Growth Factors Are Influencing Prostate Cancer Drugs Market Expansion?
The prostate cancer drugs market is being driven by the growing male geriatric population. Older men, particularly those aged 65 and above, are more likely to develop prostate cancer. According to the American Cancer Society, 6 in 10 prostate cancer cases occur in men aged 65 or older, with the ACL projecting a 21.6% rise in the elderly population by 2040, supporting market demand.
Who Are the Dominant Players Across Different Prostate Cancer Drugs Market Segments?
Major companies operating in the prostate cancer drugs market include Astellas Pharma Inc., AstraZeneca PLC, Johnson & Johnson, Sanofi S.A., Bayer AG, F. Hoffmann-La Roche AG, Abbott Laboratories, Pfizer Inc., Novartis International AG, F. Hoffmann-La Roche Ltd., Tolmar Inc., AbbVie Inc., Siemens Healthineers AG, Genomic Health Inc., OPKO Health Inc., Siemens TH*Care GmbH, MDxHealth SA, Myriad Genetics Inc., Janssen Biotech Inc., Clovis Oncology Inc., Merck Sharp & Dohme Corp., Dendreon Corporation, Ferring Pharmaceuticals Inc., GlaxoSmithKline plc, Ipsen Biopharmaceuticals Inc., Merck & Co. Inc., Eli Lilly and Company Inc., Bausch Health Companies Inc., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Novartis AG, Amgen Inc., Biogen Inc., Celgene Corporation, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Agios Pharmaceuticals Inc., Exelixis Inc.
What Prostate Cancer Drugs Market Trends Are Gaining Traction Across Different Segments?
Combination therapy is becoming an important treatment option for prostate cancer, especially in cases where monotherapy is ineffective. This approach involves using multiple therapies in tandem for more effective results. For example, Pfizer's Phase 3 PROSPER trial showed that combining XTANDI (enzalutamide) with androgen deprivation therapy (ADT) significantly reduced the risk of metastasis or death by 71% compared to ADT alone.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report
Which Geographic Regions Are Expected to Dominate the Prostate Cancer Drugs Market in the Coming Years?
North America was the largest region in the prostate cancer drugs market in 2023. Middle East is expected to be the fastest-growing region in the prostate cancer drugs market during the forecast period. The regions covered in the prostate cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Prostate Cancer Drugs Market?
2. What is the CAGR expected in the Prostate Cancer Drugs Market?
3. What Are the Key Innovations Transforming the Prostate Cancer Drugs Industry?
4. Which Region Is Leading the Prostate Cancer Drugs Market?
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prostate Cancer Drugs Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis here
News-ID: 4061580 • Views: …
More Releases from The Business Research Company
Design, Research, Promotional And Consulting Services Market Expansion Continues …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Design, Research, Promotional And Consulting Services Market Size Growth Forecast: What to Expect by 2025?
The market size of design, research, promotional and consulting services has seen consistent growth in the last few years. It's projected to elevate from $4526.88 billion in 2024 to $4746.82 billion in 2025, with…
Storage Area Network Market Expansion Continues, with Forecast Valuation of $46. …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Storage Area Network Industry Market Size Be by 2025?
In the past few years, we have seen significant and speedy growth in the storage area network market size. The market, which stands at $25.08 billion in 2024, is projected to increase to $28.44 billion in 2025,…
Online Legal Services Market Expansion Continues, with Forecast Valuation of $42 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Online Legal Services Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for online legal services has seen a swift expansion in the past years. A jump from $22.05 billion in 2024 to $25.24 billion in 2025, equating to a compound annual growth…
K-12 Private Education Market Expansion Continues, with Forecast Valuation of $6 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the K-12 Private Education Market Size By 2025?
The size of the K-12 private education sector has seen robust expansion in the recent past. From being a market worth $396.86 billion in 2024, it's projected to scale up to $431.46 billion in 2025, growing at a…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
